News

Curtis brings to Catabasis more than 19 years of experience in the pharmaceutical and biotechnology industries, and has been integrally involved in the development of over 15 compounds

Prolong president Glenn Kazo said that as they move towards the clinic with Sanguinate product they are pleased to receive this level of financing for the next phase

The award is to advance the product development and commercialisation of its topical Albuterpenoid drug, a patented anti-viral therapeutic derived from East Indian Sandalwood oil (EISO), aimed at

The new AF2 facility has been designed to meet cGMP (Current Good Manufacturing Practice) requirements, to deliver a new standard for safety and quality for cell culture media

As part of the partnership, PDR Network will work with The Doctors Company to facilitate the integration of CME into REMS programs, independently evaluating the clinical, patient-safety-focused information

As part of the initiatives, Eden Prairie, Minnesota-based SurModics is reducing its total workforce by approximately 13%. The company will implement an organisational structure that reflects its three

Data presented at the Annual Congress of the European Association of Nuclear Medicine in Vienna demonstrated that Trofex rapidly detected prostate cancer localised in the prostate bed, soft

The increase was attributable primarily to Cubist’s net sales of Cubicin (daptomycin for injection) in the US, which increased 12% to $154.5m in the third quarter of 2010

Under the terms of the settlement agreement, Lupin has agreed that, except in the event of an at-risk launch by a third-party of a generic Loestrin 24 Fe